NPY1R is a novel peripheral blood marker predictive of metastasis and prognosis in breast cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

NPY1R is a novel peripheral blood marker predictive of metastasis and prognosis in breast cancer patients

Published:2014-11-20 Issue:2 Volume:9 Page:891-896
ISSN:1792-1074
Container-title:Oncology Letters
language:en
Short-container-title:

Author:

LIU LEI,XU QIAN,CHENG LUYANG,MA CHUNHU,XIAO LIJUN,XU DAWEI,GAO YAXIAN,WANG JIANPING,SONG HONGRU

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design of Novel Imidazopyrazine Derivative against Breast Cancer via Targeted NPY1R Antagonist;Anti-Cancer Agents in Medicinal Chemistry;2023-09

2. Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies;International Journal of Molecular Sciences;2023-06-09

3. Bioinformatics and network biology approach to identifying type 2 diabetes genes and pathways that influence the progression of breast cancer;Heliyon;2023-05

4. Efficacy of a 4-Week Nurse-Led Exercise Rehabilitation Program in Improving the Quality of Life in Women Receiving a Post-Mastectomy Reconstruction Using the Motiva ErgonomixTM Round SilkSurface;International Journal of Environmental Research and Public Health;2022-12-20

5. Microenvironment components and spatially resolved single-cell transcriptome atlas of breast cancer metastatic axillary lymph nodes;Acta Biochimica et Biophysica Sinica;2022-09-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP